FULGENT GENETICS, INC. Business Acquisition, Pro Forma Earnings Per Share, Diluted
FULGENT GENETICS, INC. (FLGT) reported Business Acquisition, Pro Forma Earnings Per Share, Diluted of -$0.79 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-01.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted · last filed 2026-05-01
- FULGENT GENETICS, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2026-03-31 was -$0.79.
- FULGENT GENETICS, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2025-03-31 was -$0.44.
- FULGENT GENETICS, INC. business acquisition, pro forma earnings per share, diluted for fiscal 2022 was $4.53.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month |
|---|---|---|
| 2026-03-31 | -$0.79 10-Q · filed 2026-05-01 | |
| 2025-03-31 | -$0.44 10-Q · filed 2026-05-01 | |
| 2022-12-31 | $4.53 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |